Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117113) titled 'Study on the Efficacy and Safety of Omalizumab in Treating Pediatric Allergic Asthma' on Jan. 20.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: The First Affiliated Hospital of Xi'an Jiaotong University
Condition:
Children's allergic asthma
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-01-25
Target Sample Size: Experimental group:60;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=299500
Disclaimer: Curated by HT Syndication....